These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27736941)

  • 1. A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation.
    Marshall JD; Heeke DS; Rao E; Maynard SK; Hornigold D; McCrae C; Fraser N; Tovchigrechko A; Yu L; Williams N; King S; Cooper ME; Hajjar AM; Woo JC
    PLoS One; 2016; 11(10):e0164632. PubMed ID: 27736941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane.
    Tanimura N; Saitoh S; Ohto U; Akashi-Takamura S; Fujimoto Y; Fukase K; Shimizu T; Miyake K
    Int Immunol; 2014 Jun; 26(6):307-14. PubMed ID: 24380872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.
    Dejkhamron P; Thimmarayappa J; Kotlyarevska K; Sun J; Lu C; Bonkowski EL; Denson LA; Menon RK
    Mol Cell Endocrinol; 2007 Aug; 274(1-2):35-42. PubMed ID: 17601656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
    Sauter KS; Brcic M; Franchini M; Jungi TW
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells.
    Frleta D; Noelle RJ; Wade WF
    J Leukoc Biol; 2003 Dec; 74(6):1064-73. PubMed ID: 12960264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
    Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialyl residues modulate LPS-mediated signaling through the Toll-like receptor 4 complex.
    Feng C; Stamatos NM; Dragan AI; Medvedev A; Whitford M; Zhang L; Song C; Rallabhandi P; Cole L; Nhu QM; Vogel SN; Geddes CD; Cross AS
    PLoS One; 2012; 7(4):e32359. PubMed ID: 22496731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.
    Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S
    Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4.
    Pizzuto M; Lonez C; Baroja-Mazo A; Martínez-Banaclocha H; Tourlomousis P; Gangloff M; Pelegrin P; Ruysschaert JM; Gay NJ; Bryant CE
    Cell Mol Life Sci; 2019 Sep; 76(18):3667-3678. PubMed ID: 31062071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication.
    Marr N; Turvey SE
    Innate Immun; 2012 Dec; 18(6):856-65. PubMed ID: 22535679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung.
    Bhattacharyya S; Wang W; Qin W; Cheng K; Coulup S; Chavez S; Jiang S; Raparia K; De Almeida LMV; Stehlik C; Tamaki Z; Yin H; Varga J
    JCI Insight; 2018 Jul; 3(13):. PubMed ID: 29997297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products.
    Chowdhury P; Sacks SH; Sheerin NS
    Clin Exp Immunol; 2006 Aug; 145(2):346-56. PubMed ID: 16879256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFNβ produced by TLR4-activated tumor cells is involved in improving the antitumoral immune response.
    Núñez NG; Andreani V; Crespo MI; Nocera DA; Breser ML; Morón G; Dejager L; Libert C; Rivero V; Maccioni M
    Cancer Res; 2012 Feb; 72(3):592-603. PubMed ID: 22139376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of novel TLR4 ligands by in silico screening and their functional and structural characterization in vitro.
    Honegr J; Malinak D; Dolezal R; Soukup O; Benkova M; Hroch L; Benek O; Janockova J; Kuca K; Prymula R
    Eur J Med Chem; 2018 Feb; 146():38-46. PubMed ID: 29407964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin.
    Furuta T; Imajo-Ohmi S; Fukuda H; Kano S; Miyake K; Watanabe N
    Eur J Immunol; 2008 May; 38(5):1341-50. PubMed ID: 18398934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional signaling by Toll-like receptor 4.
    Brunn GJ; Bungum MK; Johnson GB; Platt JL
    FASEB J; 2005 May; 19(7):872-4. PubMed ID: 15738005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling.
    Sestito SE; Facchini FA; Morbioli I; Billod JM; Martin-Santamaria S; Casnati A; Sansone F; Peri F
    J Med Chem; 2017 Jun; 60(12):4882-4892. PubMed ID: 28471658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD14 but not MD2 transmit signals from DAMP.
    Chun KH; Seong SY
    Int Immunopharmacol; 2010 Jan; 10(1):98-106. PubMed ID: 19840871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.